Epiblastic Cited2 deficiency results in cardiac phenotypic heterogeneity and provides a mechanism for haploinsufficiency by MacDonald, Simon T. et al.
Epiblastic Cited2 deﬁciency results in cardiac
phenotypic heterogeneity and provides
a mechanism for haploinsufﬁciency
Simon T. MacDonald1†, Simon D. Bamforth1†, Chiann-Mun Chen1, Cassandra R. Farthing1,
Angela Franklyn1, Carol Broadbent1,J u ¨rgen E. Schneider1, Yumiko Saga2,
Mark Lewandoski3, and Shoumo Bhattacharya1*
1Department of Cardiovascular Medicine, University of Oxford, Wellcome Trust Centre for Human Genetics, Roosevelt Drive,
Headington, Oxford OX3 7BN, UK;
2Division of Mammalian Development, National Institute of Genetics, Yata 1111, Mishima
411-8540, Japan; and
3Genetics of Vertebrate Development Section, National Cancer Institute, Frederick Cancer Research
and Development Center, Box B, Building 539, Frederick, MD 21702, USA
Received 29 October 2007; revised 27 March 2008; accepted 15 April 2008; online publish-ahead-of-print 25 April 2008
Time for primary review: 31 days
Aims Deletion of the transcription factor Cited2 causes penetrant and phenotypically heterogenous
cardiovascular and laterality defects and adrenal agenesis. Heterozygous human CITED2 mutation is
associated with congenital heart disease, suggesting haploinsufﬁciency. Cited2 functions partly via a
Nodal!Pitx2c pathway controlling left–right patterning. In this present study we investigated the
primary site of Cited2 function and mechanisms of haploinsufﬁciency.
Methods and results A Cited2 conditional allele enabled its deletion in particular cell lineages in mouse
development. A lacZ reporter cassette allowed indication of deletion. Congenic Cited2 heterozygous
mice were used to investigate haploinsufﬁciency. Embryos were examined by magnetic resonance
imaging, by sectioning and by quantitative real-time polymerase chain reaction (qRT-PCR). Epiblast-
speciﬁc deletion of Cited2 using Sox2Cre recapitulated penetrant and phenotypically heterogenous car-
diovascular and laterality defects. Neural crest-speciﬁc deletion using Wnt1Cre affected cranial ganglia
but not cardiac development. Mesodermal deletion with Mesp1Cre resulted in low penetrance of septal
defect. Mesodermal deletion with T-Cre resulted in adrenal agenesis, but infrequent cardiac septal and
laterality defects. b-Galatactosidase staining and qRT-PCR demonstrated the efﬁciency and location of
Cited2 deletion. Murine Cited2 heterozygosity is itself associated with cardiac malformation, with three
of 45 embryos showing ventricular septal defect. Cited2 gene expression in E13.5 hearts was reduced
2.13-fold in Cited2
þ/2 compared with wild-type (P ¼ 2.62   10
26). The Cited2 target gene Pitx2c
was reduced 1.5-fold in Cited2
þ/2 (P ¼ 0.038) hearts compared with wild-type, and reduced 4.9-fold
in Cited2
2/2 hearts (P ¼ 0.00031). Pitx2c levels were reduced two-fold (P ¼ 0.009) in Cited2
þ/2
embryos, in comparison with wild-type. Cited2 and Pitx2c expression were strongly correlated in
wild-type and Cited2
þ/2 hearts (Pearson rank correlation ¼ 0.68, P ¼ 0.0009). Cited2 expression was
reduced 7474-fold in Sox2Cre deleted hearts compared with controls (P ¼ 0.00017) and Pitx2c was
reduced 3.1-fold (P ¼ 0.013). Deletion of Cited2 with Mesp1Cre resulted in a 130-fold reduction in
cardiac Cited2 expression compared with control (P ¼ 0.0002), but Pitx2c expression was not affected.
Conclusion These results indicate that phenotypically heterogenous and penetrant cardiac malfor-
mations in Cited2 deﬁciency arise from a primary requirement in epiblast derivatives for left–right pat-
terning, with a secondary cell-autonomous role in the mesoderm. Cardiac malformation associated with
Cited2 haploinsufﬁciency may occur by reducing expression of key Cited2 targets such as Pitx2c.
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The transcription factor CITED2 binds the histone
acetyltransferase CREBBP/EP300 with high afﬁnity,
1 acting
as a co-activator for transcription factors, such as TFAP2,
LHX2, PPARA, and SMAD2/3.
2–5 It also acts as a repressor
of hypoxia-activated transcription.
1 Genetic evidence indi-
cates that Cited2 is essential for cardiac, adrenal, neural,
and placental development, and also for embryonic left–
right patterning.
6–8 The cardiac malformations in mice
lacking Cited2 are highly penetrant and phenotypically het-
erogeneic, and include atrial, atrioventricular, and
ventricular septal defects (ASD, AVSD, VSD), outﬂow tract
defects [double outlet right ventricle (DORV), common
arterial trunk (CAT), tetralogy of Fallot (TOF), transposition
of great arteries (TGA)], and interrupted and right-sided
aortic arch.
6,9 Mutation in Cited2 also results in adrenal
agenesis, fusion of cranial ganglia, abnormal cardiac
neural crest migration, and exencephaly.
6
In addition, Cited2
2/2 mice show left–right patterning
defects characterized by right atrial and pulmonary isomer-
ism, and abnormal ventricular topology at a lower pene-
trance.
7,8 Cardiovascular left–right patterning is created,
in part, by the left-determining Nodal!Pitx2c pathway
(reviewed by Hamada et al.
10 and Ramsdell
11). Genetic evi-
dence shows that Cited2 is necessary for expression of
Pitx2c, Nodal, and Lefty2 in the left-lateral plate mesoderm
and of Lefty1 in the prospective ﬂoor plate, and is present at
the promoter of the endogenous Pitx2c gene during develop-
ment.
7,8 Thus, Cited2 is necessary for Nodal-activated gene
transcription.
7 The mechanism for the cardiovascular
phenotypic heterogeneity and the partial penetrance of
left–right patterning defect, which is observed even on a
congenic Cited2-deﬁcient background,
7 is not clear. Impor-
tantly, loss-of-function mutations in CITED2 have been
found in patients with phenotypically variable congenital
heart disease.
12 These mutations are heterozygous,
suggesting haploinsufﬁciency, but the mechanism for this is
unclear.
Cited2 is expressed before gastrulation in the visceral
endoderm.
13 Following gastrulation it is present in the
newly forming mesoderm, developing blood islands,
cardiac crescent, presomitic and splanchnic mesoderm,
cranial neuroectoderm, and migrating neural crest before
becoming ubiquitously expressed by embryonic day
(E)8.5.
13 In the heart, it is highly expressed in the AV endo-
cardial cushions.
8 One possible mechanism for cardiac phe-
notypic heterogeneity in Cited2 deﬁciency is that not only
is it required for the earlier process of left–right patterning
but also independently for the later processes of atrioventri-
cular septation, outﬂow tract, and aortic arch develop-
ment.
8 Abnormal patterning of aortic arches and CAT
observed in Cited2 deﬁciency could, for instance, arise
from defective neural crest development.
6 An alternative
possibility is that an abnormality in the earlier developmen-
tal process of left–right patterning may secondarily affect
the subsequent processes of atrioventricular septal,
outﬂow tract, or aortic arch development.
7 These different
mechanisms were investigated with a conditional knockout
approach. We also investigated the mechanism of haploin-
sufﬁciency using quantitative analysis of Cited2 and its
target gene Pitx2c. We show that the phenotypic heterogen-
eity in Cited2 deﬁciency is because of a primary
requirement in epiblast derivatives with a secondary
cell-autonomous role in the mesoderm. Also, Cited2 haplo-
insufﬁciency may cause cardiac malformation by reducing
expression of key Cited2 targets such as Pitx2c.
2. Methods
2.1 Molecular biology
Standard molecular biology procedures were used for plasmid
constructions.
14
2.2 Generation of Cited2
ﬂox/ﬂox mice
The targeting vector strategy and generation of correctly targeted
embryonic stem cells with a conditional Cited2 allele (Cited2
ﬂox
or Cited2
f) is shown in Supplementary material online, Figure S1.
Methods are also provided in detail in the Supplementary data.
The allele was designed such that, after successful Cre recombina-
tion, a lacZ expression cassette came under the control of the
endogenous Cited2 promoter. This allowed indication of efﬁcient
recombination by b-galactosidase staining.
2.3 Conditional deletion of Cited2
Cited2
þ/2 mice (Cited2
tm1Bha) on a C57BL/6J background
7 were
crossed with Sox2Cre (Tg(Sox2-cre)1Amc),
15 Wnt1Cre
(Tg(Wnt1-cre)11Rth)
16 (both gifts from Andrew McMahon, Harvard
University), Mesp1Cre (Mesp1tm2(cre)Ysa)
17 or TCre
18 mice to gen-
erate males with Cited2
þ/2;Cre genotypes. These males were
crossed to Cited2
ﬂox/ﬂox females on a mixed 129Sv   C57BL/6J
background to generate embryos with Cited2
2/ﬂox;Cre and
Cited2
þ/ﬂox;Cre (control) genotypes. This strategy prevented
global recombination owing to Cre expression in the maternal germ-
line.
19 Cited2
2/ﬂox;Cre embryos lack Cited2 expression in cells
expressing Cre-recombinase. Cited2
þ/ﬂox;Cre embryos continue to
express Cited2, providing littermate controls. Embryos were har-
vested at the indicated time points after the detection of a
vaginal plug (E0.5), and genotyped using allele-speciﬁc polymerase
chain reaction (PCR) (primer details are available on request). All
mouse experiments conform with the Guide for the Care and Use
of Laboratory Animals published by the National Institutes of
Health (NIH Publication No. 85-23, revised 1996).
2.4 Analysis of embryos
Magnetic resonance imaging (MRI) was performed on a horizontal
9.4 T/21 cm VNMRS Direct DriveTM MR system (Varian Inc., Palo
Alto, CA, USA) essentially as described previously
20 on embryos at
E15.5. Whole mount in situ immunostaining was performed on
E9.5 embryos using anti-neuroﬁlament antibody (clone 2H3, Devel-
opmental Studies Hybridoma Bank, University of Iowa, IA, USA).
21
X-Gal and nuclear fast red (Sigma, St. Louis, MO, USA) staining
were performed according to standard procedures.
14,16
2.5 Quantitative real time-polymerase chain
reaction
Embryo hearts (E13.5) were dissected out initially in DEPC treated
phosphate-buffered saline (PBS), and then ﬁnely dissected in RNAla-
ter (Ambion, Austin, TX, USA) to remove mediastinal tissue.
Embryos at E8.5 were dissected free from the yolk sac in cold
DEPC–PBS and ﬂash-frozen in liquid nitrogen. RNA was isolated
using a Nucleospin RNA puriﬁcation kit (Clontech, Palo Alto, CA,
USA), and an Archive cDNA kit (Ambion) used to synthesize comp-
lementary DNA. Quantitative RT-PCR (qRT-PCR) reactions were
carried out using a Bio-Rad I-Cycler (Bio-Rad, CA, USA) and pre-
optimized TaqManw primer-probe sets from Applied Biosytems
(Mus musculus assays Mm00516121_m1 (for NM_010828 Cited2),
Cited2 deﬁciency and cardiac phenotypic heterogeneity 449Mm00440826_m1 (for NM_001042502 Pitx2c), and eukaryotic 18S
rRNA). Expression levels were normalized to 18S rRNA using the R0
method of analysis.
22,23 Multiplex reactions were performed with
18S rRNA and the TaqMan primer-probe set for the gene of interest.
Data were normalized to the level obtained for 18S RNA in each
case. All reactions were performed in triplicates and, as a quality
control, only samples for which the threshold cycle (Ct) replicate
values were within 1 Ct value of each other were used for sub-
sequent analysis.
24 Mean values for each reaction triplicate were
analysed.
2.6 Statistical analyses
We used the chi-squared test for deviation from expected Mendelian
ratios (http://www.kursus.kvl.dk/shares/vetgen/_Popgen/genetik/
applets/ki.htm), and calculated probability of a type I error using
the CHIDIST function in Microsoft Excel (Redmond, WA, USA). For
analysis of the qRT-PCR data, we used a two-tailed, two-sample
heteroscedastic t-test assuming unequal variance.
3. Results
3.1 Deletion of Cited2 in the epiblast
To determine the role of Cited2 in the epiblast it was
deleted using Sox2Cre which induces recombination in all
epiblast cells by E6.5.
15. Genotyping of mice at weaning
showed a complete absence of Cited2
2/ﬂox;Sox2Cre
embryos, but genotyping at E15.5 showed that these
embryos were present in the expected Mendelian ratio (Sup-
plementary material online, Table S1). This indicated that
Cited2
2/ﬂox;Sox2Cre embryos die either in late gestation
or perinatally. Two of 10 Cited2
2/ﬂox;Sox2Cre embryos at
E15.5 had visible exencephaly (not shown). Analysis of
Cited2
2/ﬂox;Sox2Cre embryos at E15.5 using MRI showed
that they frequently had a classical cardiac laterality
defect, i.e. right-atrial isomerism, associated with right-
pulmonary isomerism (six of 10 embryos) (Figure 1; see
also see Supplementary material online, Table S2), indicat-
ing a defect in embryonic left–right patterning. VSDs were
present in all embryos (see Supplementary material online,
Table S2). The embryos invariably had adrenal agenesis
(see Supplementary material online, Figure S2). No defects
were seen in the 11 littermate control Cited2
þ/ﬂox;Sox2Cre
or in eight Cited2
2/ﬂox
embryos.
3.2 Deletion of Cited2 in the neural crest
To determine the requirement for Cited2 in the neural crest
it was deleted using Wnt1Cre, which drives expression of
Cre-recombinase in all neural crest-derived tissues, includ-
ing the cardiac neural crest, from E9.
16,25,26 There was a sig-
niﬁcant reduction in the numbers of Cited2
2/ﬂox;Wnt1Cre
mice in comparison with Cited2
þ/ﬂox;Wnt1Cre mice at
weaning [21 of 61 vs. 40 of 61, respectively (x
2 ¼ 5.9;
P , 0.015). There was no observed reduction when genotyp-
ing was performed between E9.5 and E18.5. Examination of
embryos at E15.5–E18.5 (n ¼ 16) using MRI revealed none
with heart or great vessel defects, but one embryo had
exencephaly (Figure 2B). Exencephaly was not observed in
Cited2
þ/ﬂox;Wnt1Cre embryos (n ¼ 16). Examination of
cranial ganglia by anti-neuroﬁlament staining in Cited2
2/
ﬂox;Wnt1Cre embryos showed that 11 of 14 sets had
fusions of ganglia IX and X (Figure 2E and F) and hypo-
morphic ganglia V and VII/VIII. In contrast, two of 28 sets
of ganglia from Cited2
þ/ﬂox;Wnt1Cre embryos had fusions
of ganglia IX and X (x
2 ¼ 22.28; P , 0.001). In both
Cited2
2/ﬂox;Wnt1Cre and in Cited2
þ/ﬂox;Wnt1Cre embryos,
we observed extensive lacZ staining in the cranial mesench-
yme, and in the ﬁrst and second pharyngeal arches
Figure 1 Deletion of Cited2 in the epiblast: cardiac morphology. Magnetic resonance imaging of E15.5 embryos. (A–D) Transverse sections and three-
dimensional (3D) reconstructions (dorsal views) of Cited2
þ/ﬂox;Sox2Cre (control) and Cited2
2/ﬂox;Sox2Cre hearts. (A, B) Control normal heart showing a pecti-
nated (P) right atrium (RA), with a systemic venous sinus (SVS), into which drains the right superior caval vein (RSCV), the left superior caval vein (LSCV) via the
coronary sinus (CS) and the inferior caval vein (ICV). The left atrium (LA) is characterized by the primary atrial septum (PAS). Other structures seen are right and
left ventricles (RV, LV), interventricular septum (IVS), and the mitral and tricuspid valves (MV, TV not labelled). (C, D) Cited2
2/ﬂox;Sox2Cre heart showing a large
primum atrial septal defect (ASDP), resulting in a common atrium (A). This is pectinated on each side and has bilateral systemic venous sinuses (LSVS, RSVS), into
which drains the bilateral superior and inferior caval veins. The coronary sinus is absent. These appearances indicate right atrial isomerism. A common atrioven-
tricular valve (CAVV) over-rides a ventricular septal defect (VSD). Note also that the heart is malpositioned to the right. (E–J) Coronal sections and 3D reconstruc-
tions (ventral views) of Cited2
þ/ﬂox;Sox2Cre (control) and Cited2
2/ﬂox;Sox2Cre hearts. (E, F) Control normal heart where the right ventricle is dextral to the left,
and gives rise to the main pulmonary trunk (PT). The left ventricle gives rise to the aorta (Ao), which arches to the left of the trachea (Tr) over the left main
bronchus. (G, H) Cited2
2/ﬂox;Sox2Cre heart with normal ventricular topology, cardiac dextroposition, and a right-sided aortic arch arising from the right ven-
tricle. (I, J) Cited2
2/ﬂox;Sox2Cre heart with abnormal ventricular topology: the right ventricle is sinistral (and anterior) to the left ventricle. Scale bars ¼
500 mm; axes: D, dorsal; V, ventral; R, right; L, left; A, anterior; P, posterior.
S.T. MacDonald et al. 450(Figure 2G and H). Staining was also observed in the cardiac
neural crest (the third and fourth/sixth pharyngeal arches).
The staining pattern corresponded to that described with
Wnt1Cre-driven recombination in R26R mice that express
lacZ conditional to Cre-mediated recombination.
16
3.3 Deletion of Cited2 in the mesoderm
The role of Cited2 in the cranial, cardiac, and extraembryo-
nic mesoderm was examined by deletion using crosses with
Mesp1Cre mice, which deletes in these tissues by E7.5.
17,27
As this Cre allele is a ‘knockin’ and disrupts the endogenous
gene, we analysed genotypic ratios of offspring born by
crossing these lines with Cited2
þ/2 mice to determine if
there was a genetic interaction. The number of Cited2
þ/2;
Mesp1Cre
þ/KI mice at weaning was similar to Cited2
þ/þ;
Mesp1Cre
þ/KI mice indicating no signiﬁcant genetic inter-
action (Supplementary material online, Table S3). Isolated
septal defects (but no outﬂow or aortic arch defects) were
seen in three of 18 Cited2
2/ﬂox;Mesp1Cre embryos and no
defects were seen in the seven Cited2
þ/ﬂox;Mesp1Cre or
nine Cited2
2/ﬂox littermate control embryos studied (Sup-
plementary material online, Figure S3). The deletion of
Cited2 using a TCre driver was then investigated. This
would be expected to delete extensively in the lateral-
plate, intermediate, and paraxial mesoderm and the
hindgut endoderm, with earliest deletion being detected
by E7.5
18. Deletion of Cited2 using TCre resulted in frequent
adrenal agenesis (10 of 14 embryos), and infrequent cardiac
septal and left–right patterning defect (three of 14 and one
of 14, respectively, Figure 3). No defects were identiﬁed in
the 11 Cited2
þ/ﬂox;TCre littermate control embryos studied.
3.4 Analysis of Cited2 recombination
3.4.1 LacZ staining
The above results indicate that Cited2 deﬁciency induced by
Wnt1Cre, Mesp1Cre,o rTCre drivers cannot explain either
the phenotypic heterogeneity or penetrance of cardiac mal-
formation and left–right patterning defects observed in the
epiblast-speciﬁc deletion of Cited2. To explore the mechan-
ism and evaluate the efﬁciency of recombination we exam-
ined the expression of lacZ in these different Cited2
þ/
ﬂox;Cre embryos at E9.5 in comparison with Cited2
þ/ﬂox;-
Sox2Cre (Figure 4 and Supplementary material online,
Table S4). Deletion of exon 2 by Cre-recombinase brings
the lacZ cassette under control of the endogenous Cited2
promoter, so analysis of lacZ expression allowed the conﬁr-
mation of Cited2
ﬂox
recombination in the embryonic lineages
where both the Cre driver and Cited2 are expressed. In the
heart, we observed staining resembling the Sox2Cre pattern
using Mesp1Cre, consistent with effective recombination in
the cardiogenic mesoderm.
17,27 Reduced lacZ staining was
observed in the outer curvature of the left ventricle
suggesting that Cited2 is not highly expressed here
(Figure 4). With TCre we observed complete recombination
in the common atrial chamber, but partial recombination in
the atrioventricular canal, primitive ventricle, bulbus
cordis, and outﬂow tract. The lateral plate mesoderm is
thought to play a key role in establishing left–right pattern-
ing (reviewed in Hamada et al.
10). We therefore examined
the expression of lacZ in structures derived from the
lateral plate mesoderm: these include the mesenchyme of
the body wall (somatopleure) and of the viscera (splanchno-
pleure).
28 In Cited2
þ/ﬂox;Sox2Cre embryos, strong lacZ
expression was observed in the splanchnopleure, and
weaker expression in the somatopleure. With TCre and
Mesp1Cre, lacZ expression was detected chieﬂy in the pos-
terior splanchnopleure surrounding the midgut. No lacZ
staining was detected in the somatopleure.
Figure 2 Deletion of Cited2 in the neural crest. Control (Cited2
þ/
ﬂox;Wnt1Cre, left panels) and mutant (Cited2
2/ﬂox;Wnt1Cre, right panels)
embryos were analysed at different stages of development. (A, B) Control
and mutant E17.5 embryos, respectively. The mutant embryo has exence-
phaly. (C, D) Magnetic resonance imaging (MRI) transverse sections of E17.5
control and mutant embryos. No cardiac or aortic arch abnormalities were
identiﬁed in 14 mutant embryos examined by MRI. (E, F) Anti-neuroﬁlament
antibody staining of control and mutant E9.5 embryos showing cranial
ganglia. The ﬁfth (trigeminal ganglion) is smaller, and the ninth and tenth
(glossopharyngeal and vagal) ganglia are fused in the mutant. (G, H) LacZ
staining of control and mutant embryos. Extensive staining is observed in
the cranial mesenchyme, and in the ﬁrst and second pharyngeal arches. Stain-
ing is also observed in the cardiac neural crest (the third and fourth/sixth
pharyngeal arches). No difference was observed in either case. The otic
vesicle (O) is indicated. Axes and abbreviations are as shown in Figure 1.
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tal stages (Supplementary material online, Figure S4). At
earlier stages, in Cited2
þ/ﬂox;Sox2Cre embryos at E7.5,
lacZ expression was present in all epiblast-derived tissues,
including the extraembryonic mesoderm. In Cited2
þ/
ﬂox;TCre embryos, we observed lacZ staining in the extraem-
bryonic mesoderm, amnion, and blood islands, and also
to some extent in the nascent embryonic mesoderm.
This became more extensive in the primitive streak and
migrating embryonic mesoderm at slightly later stages.
Examination of head-fold stage Cited2
þ/ﬂox;Mesp1Cre
embryos showed extensive recombination in the cardiac
crescent (Supplementary material online, Figure S4).
3.4.2 Quantitative real-time polymerase chain reaction
To verify efﬁcient deletion of Cited2 in the Sox2Cre and
Mesp1Cre conditional knockouts at the mRNA level, and to
determine the effect on the Cited2 target gene Pitx2c,
qRT-PCR was performed. Cited2 expression was reduced
7474-fold (P ¼ 0.00017) in Cited2
2/ﬂox;Sox2Cre hearts com-
pared with littermate controls (Figure 5A). There was also a
3.1-fold reduction in Pitx2c expression (P ¼ 0.013;
Figure 5B). Cited2 expression was reduced 130-fold in
Cited2
2/ﬂox;Mesp1Cre hearts compared with littermate con-
trols (Figure 5C). However, no reduction in Pitx2c expression
was seen in these hearts (Figure 5D).
3.5 Cited2 haploinsufﬁciency in the mouse
The mutations found in human congenital heart disease
patients
12 suggested that Cited2 haploinsufﬁciency may
occur. We tested for this in the mouse by examining the gen-
otypic ratios of Cited2
þ/2 intercrosses where we obtained
500 wild-type and 782 Cited2
þ/2 pups (expected 855).
The 8.5% reduction in Cited2
þ/2 pups was statistically sig-
niﬁcant (x
2 ¼ 18.5; P , 0.0001). A similar reduction was
not observed however when the genotypic ratios of E13.5
or E15.5 embryos were examined (Supplementary material
online, Table S5).
To determine a mechanism for reduced survival, we exam-
ined Cited2
þ/2 embryos at E15.5 by MRI (Figure 6). This was
followed by histological sectioning of embryos that had
either oedema or a cardiac abnormality visible on MRI. We
found that three of 45 Cited2
þ/2 embryos had a clearly
identiﬁable VSD, and one presented with DORV with hypo-
plastic pulmonary trunk (Figure 6). These defects were not
seen in the wild-type littermate controls. Thus, heterozygo-
sity for a Cited2 null allele is associated, at low penetrance,
with cardiac malformation in the mouse, implying
haploinsufﬁciency.
3.6 Quantitative real-time-polymerase chain
reaction analysis of Pitx2c and Cited2 expression
To determine if haploinsufﬁciency in Cited2-deﬁcient hearts
is linked to abnormality in Pitx2c expression, we examined
gene expression using qRT-PCR. Embryos and hearts on a
C57BL/6J background, generated by backcrossing for 14
generations, were used to minimize the effects of genetic
background. Hearts at E13.5 were used as this is a key time-
point in cardiac septation, and embryos at E8.5 were
selected as Pitx2c is expressed asymmetrically in the left
lateral plate mesoderm at this stage. In E13.5 hearts,
Cited2 was reduced 2.13-fold in Cited2
þ/2 compared with
Figure 3 Deletion of Cited2 using TCre. Control (Cited2
þ/ﬂox;TCre, left
panels) and mutant (Cited2
2/ﬂox;TCre, right panels) embryos were analysed
at E15.5 using magnetic resonance imaging. (A) Transverse section of a
control embryo showing normal cardiac anatomy. (B) Corresponding trans-
verse section from the single mutant embryo (of 14 analysed) that showed
a laterality defect. Right atrial isomerism is indicated by bilateral systemic
venous sinuses and a common atrium created by complete absence of the
primary atrial septum. The heart is dextroposed, with abnormal ventricular
topology [dextral left ventricle (LV)] and a ventricular septal defect. (C)
Three-dimensional (3D) reconstruction of the control embryo heart showing
normal topology of the ventricles. The aorta (Ao) arises from the LV, and pul-
monary trunk (PT) from the right ventricle (RV). Both Ao and PTarch over the
left main bronchus (LMB). (D) 3D reconstruction of the mutant embryo heart
showing abnormal ventricular topology. Both Ao and PTarise from the RV and
arch over the LMB. (E) Sagittal section through the control embryo showing
normal pulmonary topology. The three lobes of the right lung are seen. The
left lung (LL) has a single lobe. (F) Sagittal section through the mutant
embryo showing right pulmonary isomerism. Both lungs have three lobes. A
fused accessory (Ac) lobe is also seen. (G, H) Sagittal sections through the
left kidney (LK) of control and mutant embryos, respectively. The adrenal
gland (Ad) is seen in the control but not in the mutant embryo. Scale
bars ¼ 500 mm. Axes and abbreviations are as shown in Figure 1.
S.T. MacDonald et al. 452wild-type (P ¼ 2.62   10
26)( Figure 7A). We found that the
Cited2 mRNA in Cited2
2/2 hearts was either undetectable
or, if detectable, had values ranging between 1.45   10
212
and 3.47   10
211 relative to 18S (Figure 7C), likely to rep-
resent the limits of the assay. The Cited2 target gene
Pitx2c was reduced 1.5-fold in Cited2
þ/2 (P ¼ 0.038)
hearts and 4.7-fold (P ¼ 0.00031) in Cited2
2/2 hearts com-
pared with wild-type controls (Figure 7B and D). Cited2 and
Pitx2c mRNA were strongly correlated in wild-type and
Cited2
þ/2 hearts (Pearson rank correlation ¼ 0.68, P ¼
Figure 4 LacZ expression in Cited2
þ/ﬂox;Cre embryos. The left panels show pictures of embryos (E9.5) with the indicated genotypes after staining for lacZ.
Subsequent panels show transverse embryo sections counterstained with nuclear fast red. ACV, anterior cardinal vein; AVC, atrioventricular canal; BA, branchial
arch; BC, bulbus cordis; CAC, common atrial chamber; CCV, common cardinal vein; DA, dorsal aorta; FG, foregut; HD, hepatic diverticulum; HG, hindgut; HGD,
hindgut diverticulum; HM, head mesenchyme; LB, lung bud; LM, lateral mesenchyme from splanchnopleure; MG, midgut; NC, nephric cord (intermediate
mesenchyme); NT, neural tube; OFT, outﬂow tract; PC, peritoneal cavity; PPC, pleuroperitoneal canal; PV, primitive ventricle; ST, septum transversum; S,
somite. Scale bars ¼ 500 mm. Axes are as shown in Figure 1.
Figure 5 Cited2 and Pitx2c mRNA levels in Cited2 conditionally deleted hearts at E13.5. Sample mean and SEM are indicated. (A) Cited2 mRNA levels were
reduced 7474-fold in Cited2
2/ﬂox;Sox2Cre hearts compared with controls. (B) A signiﬁcant 3.1-fold decrease in Pitx2c mRNA levels was found in Cited2
2/ﬂox;-
Sox2Cre hearts compared with controls. (C)I nCited2
2/ﬂox
;Mesp1Cre hearts, Cited2 levels were reduced 130-fold compared with controls. (D) No signiﬁcant differ-
ence in Pitx2c expression was found between Cited2
2/ﬂox;Mesp1Cre hearts and controls.
Cited2 deﬁciency and cardiac phenotypic heterogeneity 4530.0009; Figure 7F). In the E8.5 embryos, we found a two-fold
reduction in Pitx2c levels in Cited2
þ/2 compared with wild-
type (P ¼ 0.009; Figure 7E).
4. Discussion
In these experiments, we used a conditional knockout
approach to understand how Cited2 deﬁciency results in
cardiac phenotypic heterogeneity. To deﬁne the role of
Cited2 in the epiblast, we deleted it with Sox2Cre.
15 This
resulted in 100% penetrance of cardiovascular malfor-
mations and adrenal agenesis. The most common cardiac
malformation was a VSD, which was present in all
embryos, and was associated with DORV in some embryos.
In addition we observed left–right patterning, atrial
septal, outﬂow tract, and aortic arch defects. These
observations are consistent with, and fully recapitulate,
those previously reported with the global deletion of
Cited2.
6–9,29 They indicate that Cited2 is essential in the
epiblast or its derivatives for normal embryonic left–right
patterning, and for cardiac and adrenal development. The
complete penetrance of the defects, and the widespread
expression of lacZ in embryos containing a Cited2
ﬂox allele
and the Cre transgene also indicate that efﬁcient recombi-
nation occurs in response to Cre expression. This was
further validated by the large reduction seen in Cited2
mRNA levels in the hearts of Cited2
2/ﬂox;Sox2Cre
embryos. We observed reduced lacZ staining in the outer
curvature of the left ventricle following conditional deletion
of Cited2 with Sox2Cre (as well as with Mesp1Cre and TCre).
This is consistent with the published data,
8 and indicates
that Cited2 is expressed at a lower level in this region of
the heart.
To deﬁne the role of Cited2 in the neural crest, we
deleted it with Wnt1Cre.
16,30 This resulted in cranial
ganglia fusions and exencephaly, but did not affect cardiac
septal, outﬂow tract, aortic arch or adrenal development,
or left–right patterning. These results indicate that although
Cited2 does have a cell autonomous role in the neural crest,
as evidenced by fusion of the cranial ganglia, it is not
required here for outﬂow tract septation or aortic arch
patterning.
To determine the requirement of Cited2 in the cranial,
cardiac, and extraembryonic mesoderm it was deleted
with Mesp1Cre, which results in extensive recombination
in these tissues by E7.5.
17,27 Subsequently, by E9.5, recom-
bination is observed extensively in myocardium and endo-
cardium including the mesenchyme of the cono-truncal
and atrioventricular cushions, in the epicardium, and in
the pharyngeal arch mesoderm and vascular endo-
thelium.
17,27,31 Deletion of Cited2 using Mesp1Cre resulted
in low penetrance of septal defect, and no outﬂow tract,
aortic arch, or laterality defects. These results indicate
that Cited2 function in the mesoderm does not explain the
phenotypically heterogeneic cardiac malformations
observed in the epiblast-speciﬁc deletion. Efﬁcient recombi-
nation at the Cited2 locus in response to Cre expression as
demonstrated by lacZ staining and qRT-PCR indicated that
lack of a phenotypically heterogeneic phenotype is unlikely
to be owing to inefﬁcient recombination.
As Cited2 is expressed in the lateral-plate mesoderm,
8
and as its deﬁciency also leads to loss of Nodal-activated
transcripts such as a Nodal, Lefty2, and Pitx2c in the
left-lateral plate mesoderm,
7,8 we investigated its role
here by deletion using TCre.
18 This resulted in infrequent
septal and laterality defect. Deletion of Cited2 induced by
TCre was predominantly in the posterior rather than the
anterior extent of the lateral plate mesoderm, making this
one possible mechanism for the infrequency of left–right
patterning defect observed with a TCre-induced deletion.
The lacZ staining pattern seen in Cited2
þ/ﬂox;TCre
embryos was comparable with that seen with TCre   R26R
lacZ embryos.
18 Moreover, in the heart the staining pattern
was highly reminiscent of that observed for Isl1
32 suggesting
that TCre may also drive recombination in second heart
ﬁeld-derived regions of the heart. These results indicate
that the penetrant and phenotypically heterogeneic
cardiac malformations in Cited2 deﬁciency arise from a
primary requirement in epiblast derivatives for left–right
Figure 6 Oedema and cardiac malformations in Cited2
þ/2 embryos. Mag-
netic resonance imaging of wild-type and littermate Cited2
þ/2 embryos at
E15.5. Sagittal sections of wild-type (A) and Cited2
þ/2 (B) embryos. Severe
oedema (asterisks) is seen in the Cited2
þ/2 embryo. (C) Transverse section
of wild-type and Cited2
þ/2 embryos. The Cited2
þ/2 embryo has a ventricular
septal defect (VSD) (D). (E, F) Three-dimensional reconstruction of the heart
in the wild-type and Cited2
þ/2 embryos shown in the previous panel. The
aorta (Ao) and pulmonary artery (PA) arise from the left ventricle and right
ventricle (RV), respectively, in the wild-type embryo, but in the Cited2
þ/2
embryo they arise from the RV creating a double-outlet right ventricle
(DORV). VSD is indicated. Scale bars, 500 mm. Axes are as shown in Figure 1.
S.T. MacDonald et al. 454patterning with a secondary cell-autonomous role in the
mesoderm for septation. A limitation of our studies,
however, is that the role of Cited2 in the endoderm—which
has a major role in cardiac induction
33—could not be estab-
lished. We are currently limited here by the lack of a suit-
able Cre driver that expresses in the endoderm at the
appropriate time-point.
Our data also show that Cited2 haploinsufﬁciency occurs
in the mouse and is associated with cardiac malformation.
Although 8.5% of Cited2 heterozygous pups are lost by
weaning, consistent with the numbers of cardiac malfor-
mations observed, no deviation from expected numbers
was seen during development. The mechanistic link
between cardiac malformations and Cited2 haploinsufﬁ-
ciency is unclear, and to address this, we quantitatively
examined the expression of Cited2 and its target gene
Pitx2c in embryonic hearts and E8.5 embryos. Using
qRT-PCR we showed that Cited2 expression is signiﬁcantly
reduced in Cited2 heterozygous embryonic hearts. We also
showed that this was accompanied by a signiﬁcant reduction
in Pitx2c expression, and that the two were strongly corre-
lated. We also observed a signiﬁcant reduction in Pitx2c
levels in E8.5 Cited2
þ/2 embryos. As the dose of Pitx2c is
crucial for normal left–right patterning and cardiac develop-
ment,
34,35 we suggest that Pitx2c deﬁciency observed in
Cited2 heterozygous hearts and embryos could explain, at
least in part, the observed cardiac malformations.
In conclusion, these results indicate that phenotypically
heterogeneic and penetrant cardiac malformations in
Cited2 deﬁciency arise from a primary requirement in epi-
blast derivatives for left–right patterning with a secondary
cell-autonomous role in the mesoderm for septation.
Cardiac malformation associated with Cited2 haploinsufﬁ-
ciency may occur by reducing the expression of key Cited2
targets, such as Pitx2c from E8.5. Importantly, cardiovascu-
lar phenotypic heterogeneity is observed, for instance, with
mutation in NKX2-5,
36–38 CFC1
39,40 or ZIC3.
41–43 Consistent
with our proposed model, these genes, like Cited2, are
also known to control or modulate left–right patterning
pathways.
42,44–47 Our results support the emerging idea
7,11
that genes controlling early left–right patterning are candi-
dates for diverse forms of human congenital heart disease,
even in the absence of a classical laterality defect such as
isomerism.
Figure 7 Cited2 and Pitx2c mRNA levels in E13.5 embryo hearts and E8.5 embryos. Sample mean and SEM are indicated. (A) A 2.1-fold reduction in Cited2 mRNA
levels was seen in Cited2
þ/2 hearts compared with wild-type. (B) Pitx2c levels were reduced 1.5-fold in Cited2
þ/2 hearts compared with wild-type. (C)A
92 000-fold reduction in Cited2 mRNA is seen in the Cited2
2/2 hearts compared with wild-type. (D) Pitx2c mRNA levels were reduced 4.7-fold in the
Cited2
2/2 hearts compared with wild-type. (E) Pitx2c levels in wild-type and Cited2
þ/2 E8.5 embryos. A two-fold reduction in Pitx2c mRNA is seen in the
Cited2
þ/2 embryos. (F) Pearson correlation between Cited2 and Pitx2c E13.5 heart mRNA levels with line-of-best-ﬁt and 95% conﬁdence intervals (dotted
lines) shown. Filled circles represent data from Cited2
þ/2 hearts and diamonds those from wild-type. Cited2 and Pitx2c mRNA levels were strongly correlated
in wild-type and Cited2
þ/2 hearts.
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